Malnique, F. (2025) “USE OF DAPAGLIFLOZIN (FORXIGA) IN THE MANAGEMENT OF OBESITY AND NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH TYPE 2 DIABETES”, Seven Editora, pp. 368–379. Available at: https://sevenpubl.com.br/editora/article/view/8517 (Accessed: 21 November 2025).